ORAMED PHARMACEUTICALS INC. (ORMP)
Pharmaceutical Preparations · Healthcare · $154M
Intrinsic Value (Consensus)
$0.00
Current Price
$3.77
Margin of Safety
0%
At Fair Value
Value: $0
Price: $4
Valuation Model Estimates
Current Price: $3.77
DCF (Discounted Cash Flow)
$27.12
Graham Number
$17.22
Earnings Power Value
$21.96
Relative Value (P/E)
$51.82
Dividend Discount Model
Not applicable
—
Consensus Value
$0.00
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
67
Profitability
25/25
Strength
14/25
Valuation
12/25
Growth
16/25
Financial Health Signals
Negative free cash flow — company is burning cash
Strong profitability — ROE of 32% (above 20% is excellent)
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $2.59
- EPS (Forward)
- $2.72
- Book Value
- $5.09
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 32.1%
- Debt/Equity
- 0%
- Revenue Growth
- 49.3%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.25
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance